Author:
Zhou Rui,Qu Rui,Liu Min,Huang Dan-Ping,Zhou Jin-Yi,Chen Yan,Chen Xu-Qin
Subject
Behavioral Neuroscience,Neurology (clinical),Neurology
Reference39 articles.
1. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial;Marson;Lancet,2021
2. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies;Fiest;Neurol,2017
3. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data;Nevitt;Cochrane Database Syst Rev,2022
4. Food and Drug Administration (FDA). FYCOMPA® prescribing information; December 2021.
5. Efficacy and safety of perampanel monotherapy in patients with focal-onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open-label Study 342 (FREEDOM Study);Yamamoto;Epilepsia Open,2020
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献